Taiwan Mundipharma Pharmaceuticals Ltd.

🇹🇼Taiwan
Ownership
-
Employees
-
Market Cap
-
Website

Safety and Effectiveness of Transdermal Buprenorphine in Cancer Pain

Completed
Conditions
First Posted Date
2020-03-20
Last Posted Date
2020-03-20
Lead Sponsor
Taiwan Mundipharma Pharmaceuticals Ltd.
Target Recruit Count
83
Registration Number
NCT04315831
Locations
🇨🇳

Chang Gung Memorial Hospital- Linko Branch, New Taipei City, Taiwan

A Study to Compare the Titration Efficacy and Safety of Control-released Oxycodone and Immediate-released Oxycodone in Patients With Moderate to Severe Cancer Pain

Phase 4
Completed
Conditions
Interventions
First Posted Date
2017-06-05
Last Posted Date
2020-03-18
Lead Sponsor
Taiwan Mundipharma Pharmaceuticals Ltd.
Target Recruit Count
30
Registration Number
NCT03176199
Locations
🇨🇳

Changhua Christian Hospital, Chang-hua, Taiwan

🇨🇳

Taipei Veterans General Hospital, Taipei, Taiwan

🇨🇳

National Taiwan University Hospital, Taipei, Taiwan

and more 1 locations

Study Evaluating Safety and Tolerability of Oxycodone in Patients With Moderate to Severe Cancer Pain

Phase 4
Completed
Conditions
Interventions
First Posted Date
2017-06-05
Last Posted Date
2020-03-18
Lead Sponsor
Taiwan Mundipharma Pharmaceuticals Ltd.
Target Recruit Count
73
Registration Number
NCT03176121
Locations
🇨🇳

Chang Gung Memorial Hospital, Chiayi branch, Chiayi City, Taiwan

🇨🇳

MacKay Memorial Hospital, Taipei, Taiwan

🇨🇳

Chang Gung Memorial Hospital, Kaohsiung branch, Kaohsiung, Taiwan

and more 7 locations

Effect of Good Pain Management (GPM) Ward Program on Moderate to Severe Cancer Pain Patients

First Posted Date
2017-05-16
Last Posted Date
2017-05-16
Lead Sponsor
Taiwan Mundipharma Pharmaceuticals Ltd.
Target Recruit Count
150
Registration Number
NCT03155516
Locations
🇨🇳

Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan

🇨🇳

Kaohsiung Municipal Siaogang Hospital, Kaohsiung, Taiwan

🇨🇳

Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan

A Pralatrexate Study in Asian Patients With Peripheral T-cell Lymphoma After Prior Therapy

First Posted Date
2017-05-12
Last Posted Date
2017-05-12
Lead Sponsor
Taiwan Mundipharma Pharmaceuticals Ltd.
Target Recruit Count
22
Registration Number
NCT03150602
Locations
🇨🇳

Ntional Taiwan University Hospital, Taipei, Taiwan

© Copyright 2024. All Rights Reserved by MedPath